Kuhn Jenna M, Di Yuanpu Peter
Department of Environmental and Occupational Health, School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Pharmaceutics. 2023 Jan 12;15(1):270. doi: 10.3390/pharmaceutics15010270.
The emergence and dissemination of carbapenem-resistant (KP), one of the carbapenem-resistant (CRE), is now an emerging cause of antibiotic-resistant nosocomial infections associated with high rates of morbidity and mortality. Colistin, or polymyxin E, is a last-resort peptide antibiotic used to treat multidrug-resistant (MDR) Gram-negative bacterial infections including KP. Unfortunately, resistance to colistin is rising with increasing use in the clinical setting. Although clinical evidence links certain mutations to colistin resistance (COL-R) in KP, the origination and association of the mutations remain unclear. We hypothesize that the timing of COL-R mutations influences the development and progression of KP resistance to colistin. We performed planktonic and biofilm in vitro experimental evolutions of KP strain ATCC 43816 under increasing colistin concentrations to characterize the temporal regulation of critical COL-R mutations throughout COL-R progression. The resistance generation and mutation profiles of independently evolved bacterial populations with different lifestyles were compared. Genes with various functions theorize the timeline in which key mutations are generated and their roles in the progression of COL-R. Our results aim to advance the research and development of effective therapeutics to treat MDR bacterial infection as the dissemination of CRE continues to be a severe public health threat.
耐碳青霉烯类肺炎克雷伯菌(KP)作为耐碳青霉烯类肠杆菌科细菌(CRE)之一,其出现和传播现已成为导致抗生素耐药性医院感染的一个新原因,且发病率和死亡率很高。黏菌素,即多黏菌素E,是一种用于治疗包括KP在内的多重耐药(MDR)革兰氏阴性菌感染的最后一道防线的肽类抗生素。不幸的是,随着其在临床环境中的使用增加,对黏菌素的耐药性正在上升。尽管临床证据将某些突变与KP中的黏菌素耐药性(COL-R)联系起来,但这些突变的起源和关联仍不清楚。我们假设COL-R突变的时间会影响KP对黏菌素耐药性的发展和进程。我们在不断增加黏菌素浓度的情况下,对KP菌株ATCC 43816进行了浮游菌和生物膜的体外实验进化,以表征在COL-R进展过程中关键COL-R突变的时间调控。比较了具有不同生活方式的独立进化细菌群体的耐药性产生和突变谱。具有各种功能的基因推测了关键突变产生的时间线及其在COL-R进展中的作用。随着CRE的传播仍然是一个严重的公共卫生威胁,我们的研究结果旨在推动治疗MDR细菌感染的有效疗法的研发。